Submit your claim details for a free, no obligation case review
Get Started:
The Food and Drug Administration announced last week that all antidepressant labeling will be revised to highlight the increased risk of suicide in young adults
Antidepressants are currently required to carry a bold black box warning to alert patients to the risk of suicidal thoughts and behaviors in children and adolescents. The revised label will extend the age associated with the risk of suicidality to 25.
According to the FDA, various studies have consistently confirmed this risk, and as a result, the agency is giving antidepressant manufacturers 30 days to submit labeling revisions and create informative, easy-to-read patient Medication Guides.
In the meantime, the FDA is emphasizing the need for close monitoring and observation of patients under the age of 25 taking any antidepressant, particularly in the first one to two months of treatment.
All antidepressants, including Paxil , Prozac , Zoloft, Celexa, Effexor and Lexapro, will receive updated labeling. A more complete list of antidepressants is listed on the FDA website.
(Source: FDA website)
Injured by a defective drug? Ensure your legal rights are protected by contacting an experienced attorney near you today.